Home LiteratureArticle Details
PMID: 19726563 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.

Molecular biology of the cell ·Vol. 20 ·No. 20 ·2009-10-00 ·Pages 4362-70

Lee NY, Kirkbride KC, Sheu RD, Blobe GC

Abstract

Bone morphogenetic proteins (BMPs) signal through the BMP type I and type II receptors to regulate cellular processes, including embryonic development. The type I BMP receptors activin-like kinase (ALK)3 and ALK6 share a high degree of homology, yet possess distinct signaling roles. Here, we report that although the transforming growth factor (TGF)-beta type III receptor (TbetaRIII) enhanced both ALK3 and ALK6 signaling, TbetaRIII more potently enhanced ALK6-mediated stimulation of the BMP-responsive promoters XVent2 and 3GC2, and up-regulation of the early response gene Smad6. In contrast, TbetaRIII specifically enhanced ALK3-mediated up-regulation of the early response gene ID-1. TbetaRIII associated with ALK3 primarily through their extracellular domains, whereas its interaction with ALK6 required both the extracellular and cytoplasmic domains. TbetaRIII, along with its interacting scaffolding protein beta-arrestin2, induced the internalization of ALK6. In contrast, TbetaRIII colocalized with and resulted in the cell surface retention of ALK3, independently of beta-arrestin2. Although complex formation between TbetaRIII, ALK6, and beta-arrestin2 and TbetaRIII/ALK6 internalization resulted in maximal BMP signaling, the TbetaRIII mutant unable to interact with beta-arrestin2, TbetaRIII-T841A, was unable to do so. These studies support a novel role for TbetaRIII in mediating differential ALK3 and ALK6 subcellular trafficking resulting in distinct signaling downstream of ALK3 and ALK6.

MeSH Terms
Animals Arrestins/physiology Bone Morphogenetic Protein Receptors, Type I/physiology Bone Morphogenetic Proteins/physiology COS Cells Cell Line/metabolism Cell Line, Tumor/metabolism Chlorocebus aethiops Gene Expression Regulation/physiology Humans Kidney Mice Multiprotein Complexes/physiology Protein Interaction Mapping Protein Structure, Tertiary Protein Transport/physiology Proteoglycans/chemistry,genetics,physiology Receptors, Transforming Growth Factor beta/chemistry,genetics,physiology Signal Transduction/physiology Structure-Activity Relationship Subcellular Fractions/metabolism Teratocarcinoma/pathology beta-Arrestins
Chemicals
Arrestins Bone Morphogenetic Proteins Multiprotein Complexes Proteoglycans Receptors, Transforming Growth Factor beta beta-Arrestins betaglycan Bmpr1a protein, mouse Bmpr1b protein, mouse Bone Morphogenetic Protein Receptors, Type I
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lee Nam Y
Department of Medicine, Duke University Medical Center, Durham, NC 27708, USA.
Kirkbride Kellye C
Sheu Richard D
Blobe Gerard C
References (49)
49 references, click to expand
  1. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
    J Biol Chem. 2008 Mar 21;283(12):7628-37 PMID: 18184661
  2. Cloning and characterization of a human type II receptor for bone morphogenetic proteins.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7632-6 PMID: 7644468
  3. Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
    Cell. 2003 Jun 13;113(6):685-700 PMID: 12809600
  4. Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs.
    Oncogene. 1997 Mar 20;14(11):1377-82 PMID: 9178898
  5. Expression cloning and characterization of the TGF-beta type III receptor.
    Cell. 1991 Nov 15;67(4):797-805 PMID: 1657407
  6. Mutations of TGFbeta signaling molecules in human disease.
    Ann Med. 2006;38(6):403-14 PMID: 17008304
  7. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.
    J Biol Chem. 1996 Aug 30;271(35):21345-52 PMID: 8702914
  8. Reduced expression of BMPR-IB correlates with poor prognosis and increased proliferation of breast cancer cells.
    Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):101-8 PMID: 19451094
  9. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.
    Carcinogenesis. 2007 Dec;28(12):2491-500 PMID: 17768179
  10. The endocytic pathway: a mosaic of domains.
    Nat Rev Mol Cell Biol. 2001 Oct;2(10):721-30 PMID: 11584299
  11. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.
    Mol Biol Cell. 2000 Mar;11(3):1023-35 PMID: 10712517
  12. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.
    Mol Cell Biol. 2006 Oct;26(20):7791-805 PMID: 16923969
  13. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.
    Genes Dev. 1995 Dec 15;9(24):3027-37 PMID: 8543149
  14. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
    Cancer Res. 2002 Aug 15;62(16):4690-5 PMID: 12183427
  15. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
    Carcinogenesis. 2008 Mar;29(3):528-35 PMID: 18174241
  16. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.
    Mol Cell Biol. 1995 Jul;15(7):3479-86 PMID: 7791754
  17. Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation.
    J Biol Chem. 2008 Dec 12;283(50):34808-18 PMID: 18845534
  18. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.
    Endocrinology. 1995 Jun;136(6):2652-63 PMID: 7750489
  19. Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells.
    Oncogene. 2002 May 16;21(22):3541-51 PMID: 12032856
  20. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover.
    Nat Cell Biol. 2003 May;5(5):410-21 PMID: 12717440
  21. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages.
    J Cell Biol. 1998 Jul 13;142(1):295-305 PMID: 9660882
  22. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.
    J Biol Chem. 2000 Sep 8;275(36):27973-8 PMID: 10854429
  23. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3.
    Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2878-83 PMID: 11854453
  24. Signal transduction by bone morphogenetic proteins.
    Cytokine Growth Factor Rev. 1998 Mar;9(1):49-61 PMID: 9720756
  25. The type III TGF-beta receptor suppresses breast cancer progression.
    J Clin Invest. 2007 Jan;117(1):206-17 PMID: 17160136
  26. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
    Nat Rev Cancer. 2006 Jul;6(7):506-20 PMID: 16794634
  27. Role of transforming growth factor-beta superfamily signaling pathways in human disease.
    Biochim Biophys Acta. 2008 Apr;1782(4):197-228 PMID: 18313409
  28. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors.
    J Cell Sci. 2005 Feb 1;118(Pt 3):643-50 PMID: 15657086
  29. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
    J Biol Chem. 1994 Jun 24;269(25):16985-8 PMID: 8006002
  30. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.
    J Cell Sci. 1999 Oct;112 ( Pt 20):3519-27 PMID: 10504300
  31. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling.
    Science. 2003 Sep 5;301(5638):1394-7 PMID: 12958365
  32. Signalling via type IA and type IB bone morphogenetic protein receptors (BMPR) regulates intramembranous bone formation, chondrogenesis and feather formation in the chicken embryo.
    Int J Dev Biol. 2002 Mar;46(2):243-53 PMID: 11934153
  33. The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.
    Proc Natl Acad Sci U S A. 2009 May 19;106(20):8221-6 PMID: 19416857
  34. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
    Cancer Res. 2007 Feb 1;67(3):1090-8 PMID: 17283142
  35. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Carcinogenesis. 2008 Feb;29(2):252-62 PMID: 17999987
  36. Betaglycan presents ligand to the TGF beta signaling receptor.
    Cell. 1993 Jul 2;73(7):1435-44 PMID: 8391934
  37. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos.
    Mol Cell Biol. 2003 Jun;23(12):4371-85 PMID: 12773577
  38. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.
    Genes Dev. 1997 Apr 15;11(8):984-95 PMID: 9136927
  39. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
    J Biol Chem. 2007 Jun 22;282(25):18129-18140 PMID: 17472960
  40. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.
    Mol Cell Biol. 1994 Sep;14(9):5961-74 PMID: 8065329
  41. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.
    Cell. 1991 Nov 15;67(4):785-95 PMID: 1657406
  42. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    J Biol Chem. 1998 Jan 23;273(4):1872-9 PMID: 9442019
  43. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily.
    Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):878-83 PMID: 8570652
  44. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
    Cancer Res. 2007 Jun 1;67(11):5231-8 PMID: 17522389
  45. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
    J Cell Biol. 1995 Jul;130(1):217-26 PMID: 7790373
  46. TGFbeta signaling in growth control, cancer, and heritable disorders.
    Cell. 2000 Oct 13;103(2):295-309 PMID: 11057902
  47. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo.
    Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5062-7 PMID: 15781876
  48. Consequences of knocking out BMP signaling in the mouse.
    Genesis. 2003 Jan;35(1):43-56 PMID: 12481298
  49. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC.
    J Biol Chem. 2001 Oct 26;276(43):39608-17 PMID: 11546783
Article Info
Journal
Molecular biology of the cell
Abbr.
Mol Biol Cell
ISSN
1939-4586
Published
2009-10-00
Epub
2009-00-02
Pages
4362-70
Language
English
Region
United States
NLM ID
9201390
PMCID
PMC2762132
Subset
IM
Grants
NCI NIH HHS · R01 CA106307 · United States
NCI NIH HHS · R01 CA136786 · United States
NCI NIH HHS · R01-CA106307 · United States
NCI NIH HHS · R01-CA136786 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com